COMMUNIQUÉS West-GlobeNewswire

Globus Medical Schedules Second Quarter 2018 Earnings Release and Conference Call
16/07/2018
AUDUBON, Pa., July 16, 2018 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2018 after the [...]
SeaSpine to Report Second Quarter 2018 Financial Results on July 30, 2018
16/07/2018
CARLSBAD, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Assembly Biosciences Announces the Closing of its Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
16/07/2018
INDIANAPOLIS and SAN FRANCISCO, July 16, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) (“Assembly”), today announced the closing of its previously announced underwritten public offering of 4,600,000 [...]
Quotient Limited Announces Details of Investor Day
16/07/2018
JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ headquarters in New York [...]
Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2018 and Recent Developments
16/07/2018
-- Company Records Fiscal Year 2018 Revenue of $53.6 Million -- -- Committed Backlog Increases to $57.8 Million (ASC 605) -- -- Customer Base Expanded and Diversified -- -- Key Appointments Strengthen CDMO Leadership [...]
Evolus, Inc. Announces Proposed Public Offering of Common Stock
16/07/2018
IRVINE, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq:EOLS) (“Evolus”) announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) and [...]
I.Ceram : Strategic step forward: Obtainment of CE marking for the unloaded ceramic sternal implant
16/07/2018
Press Release Limoges, 2018, July 16 th Strategic step forward: Obtainment of CE marking for the unloaded ceramic sternal implant I.Ceram, specialized in CERAMIL® ceramic implants with great biocompatibility, just [...]
I.Ceram : Etape stratégique franchie : obtention du marquage CE pour l'implant sternal céramique non chargé
16/07/2018
Communiqué de presse Limoges, 16 juillet 2018 Etape stratégique franchie : obtention du marquage CE pour l'implant sternal céramique non chargé I.CERAM , spécialiste des implants en céramique CERAMIL® à la [...]
RavenQuest Completes Final Tranche of Oversubscribed Private Placement
16/07/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, July [...]
Nohla Therapeutics Receives FDA Orphan Drug Designation for Dilanubicel for Hematopoietic Stem Cell Transplant Patients
16/07/2018
SEATTLE, July 16, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off-the-shelf cell therapies for patients with hematologic malignancies and other critical diseases, today announced that [...]
Ossur Hf : Transactions in relation to share buyback program
16/07/2018
Announcement no. 45/2018 Reykjavik, 16 July 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada
16/07/2018
MIAMI, July 16, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) announced today that the Company’s partner Vifor Fresenius Medical Care Renal Pharma (VFMCRP) has received approval from Health Canada to market [...]
Sanofi: Disclosure of trading in own shares
16/07/2018
Attachment Disclosure of trading in own shares (pdf).pdf
Sanofi : Déclaration des transactions sur actions propres
16/07/2018
Pièce jointe Déclaration des transactions sur actions propres (pdf).pdf
SPINEWAY : Spineway reçoit le prix Forbes FUTUR40
16/07/2018
Communiqué de presse Ecully, le 16 juillet 2018 Spineway reçoit le prix Forbes FUTUR40 Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des pathologies de la colonne vertébrale (rachis [...]
Eurobio Scientific acquires Dendritics, a company specializing in antibody development and manufacture
16/07/2018
Eurobio Scientific acquires Dendritics, a company specializing in antibody development and manufacture This strategic acquisition strengthens the Group's offer for the life sciences market Paris, July 16, 2018 - 5.45 pm [...]
Eurobio Scientific acquiert la société Dendritics, spécialisée dans la fabrication d'anticorps
16/07/2018
Eurobio Scientific acquiert la société Dendritics, spécialisée dans la fabrication d'anticorps Avec cette acquisition stratégique, le Groupe renforce son offre pour la recherche en Sciences de la vie Paris, le 16 [...]
Merit Medical Systems to Announce Second Quarter Results on July 23, 2018
16/07/2018
SOUTH JORDAN, Utah, July 16, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
SELLAS Life Sciences Announces Closing of $24.2 Million Public Offering
16/07/2018
NEW YORK, July 16, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]

Pages